LTD MediClub Georgia

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Gout2 trials
• Psoriasis2 trials
• Psoriatic arthritis2 trials
• Graves' disease1 trial
• Hidradenitis suppurativa1 trial

Phase

• Phase 34 trials
• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• LG Chem2 trials
• argenx1 trial
• Navigator Medicines, Inc.1 trial

Running trials

• Recruiting

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

  NCT07596849· Phase 3· argenx· Source

  Contact: Nino Dolidze, MD

• Recruiting

  A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

  NCT07384975· Phase 2· Navigator Medicines, Inc.· Source

  Contact: Associate Director, Clinical Operations

• Active, not recruiting

  A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

  NCT04929210· Phase 4· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Active Psoriatic Arthritis

  NCT04882098· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Graves' disease1 recruiting
• Hidradenitis suppurativa1 recruiting

Closed trials

• Completed

  Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

  NCT05586971· Phase 3· LG Chem· Source

• Completed

  Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

  NCT05586958· Phase 3· LG Chem· Source